Cocrystal Pharma (COCP) Revenue (2010 - 2026)

Cocrystal Pharma (COCP) reported Revenue of $225000.0 for Q1 2026, down 55.88% sequentially from $510000.0 in Q4 2020.

Cocrystal Pharma (COCP) Revenue (2010 - 2026) Analysis & Trends

Cocrystal Pharma (COCP) has 8 years of Revenue data on file, last reported at $225000.0 in Q1 2026.

For the quarter ending Q1 2026, Revenue changed N/A year-over-year to $225000.0; the trailing twelve-month figure through Mar 2026 stood at $1.8 million (changed N/A YoY), and the FY2020 full-year result was $2.0 million, down 69.32% from the prior year.
Revenue declined to $225000.0 in Q1 2026, from $510000.0 in the prior quarter.
In the past five years, Revenue ranged from a high of $225000.0 in Q1 2026 to a low of $225000.0 in Q1 2026.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Revenue (Qtr)
1	Oculis Holding AG	66,621.14 Bn	66,620.85 Bn	-	-
2	Nanobiotix	1,915.18 Bn	1,915.11 Bn	-	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	-
4	BeOne Medicines	471.27 Bn	466.48 Bn	1.35 Bn	1.51 Bn
5	Vertex Pharmaceuticals	121.81 Bn	114.57 Bn	2.59 Bn	2.99 Bn
6	Regeneron Pharmaceuticals	69.58 Bn	60.82 Bn	3.31 Bn	3.61 Bn
7	Belite Bio	62.72 Bn	62.72 Bn	-	-
8	Argenx Se	55.51 Bn	50.33 Bn	1.41 Bn	1.56 Bn
9	Revolution Medicines	37.35 Bn	37.35 Bn	-	-
10	Cocrystal Pharma	12.57 Mn	7.74 Mn	-	225,000.00

Historic Data

Download Data

Date	Value
Mar 31, 2026	225,000.00
Dec 31, 2020	510,000.00
Sep 30, 2020	489,000.00
Jun 30, 2020	554,000.00
Mar 31, 2020	461,000.00
Dec 31, 2019	402,000.00
Sep 30, 2019	492,000.00
Jun 30, 2019	592,000.00
Mar 31, 2019	5.08 Mn
Sep 30, 2015	24,000.00
Jun 30, 2015	27,000.00
Mar 31, 2015	27,000.00
Jun 30, 2013	1.96 Mn
Mar 31, 2013	2.03 Mn
Dec 31, 2012	3.87 Mn
Sep 30, 2012	4.89 Mn
Jun 30, 2012	4.91 Mn
Mar 31, 2012	3.51 Mn
Dec 31, 2011	3.67 Mn
Sep 30, 2011	3.93 Mn